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 Abstract 
Background: Increased thoracic ascending aortic stiffness is thought to contribute to concentric left 
ventricular hypertrophy and increased mortality, a pattern seen in hypertension. As such, aortic 
stiffness and increased left ventricular mass are candidates by which obesity increases 
cardiovascular risk. However, obesity is characterized predominantly by increased abdominal 
aortic stiffness and with eccentric left ventricular hypertrophy.  
Methods: We aimed to establish whether or not, in addition to these changes, there is also an 
element of concentric remodeling in obesity that was predicted by ascending aortic stiffness. 301 
subjects underwent cardiovascular magnetic resonance imaging to measure regional aortic 
distensibility and left ventricular morphology. To compare obesity with hypertension, subjects 
were separated into groups by hypertensive status and body mass index.  
Results: In comparison to normotensive subjects, hypertension was linked with concentric 
remodeling (a 17% increase in left ventricular mass: volume ratio (LVM:VR), (p<0.001) and 
reduced ascending aortic distensibility (by 64%,p<0.001). LVM:VR was negatively correlated with 
ascending aortic distensibility (R-0.36,p<0.01). Obesity, in the absence of hypertension, was 
associated with elevated left ventricular mass when compared to normal weight normotensive 
subjects (by 27%, p<0.01), in an eccentric pattern with cavity dilatation (p<0.01). However, 
LVM:VR was also 14% larger than in normal weight normotensive subjects (p<0.01), 
indicative of additional concentric remodeling. LVM:VR in obesity was, however, not correlated 
with ascending aortic distensibility when adjusted for mean arterial pressure (R=-0.14,p<0.14). 
Conclusion: In summary, despite the predominantly eccentric pattern of left hypertrophy in 
obesity there is a concentric element of hypertrophy that, unlike in hypertension, is not linked to 
increased ascending aortic stiffness. 
  
Introduction 
Obesity per se is a well recognized risk factor for cardiovascular disease, (1, 2) 
exerting independent adverse effects on the cardiovascular system. (2, 3) Despite this well 
documented link, the mechanisms by which obesity modulates cardiovascular risk are not 
well understood. As obesity is associated with increased arterial stiffness and left ventricular 
hypertrophy, (4-8) both powerful predictors of mortality in multiple patient groups, (9) 
these have become candidate mechanisms to explain at least part of the increased mortality 
seen in obesity. In addition, weight loss in the setting of obesity has been shown to 
improve outcome and is associated with improvements in aortic stiffness and with reduced 
left ventricular mass. (10) 
Aortic stiffness is generally thought to result in increased mortality via its haemodynamic effects. 
Mechanical fatigue and fragmentation of the elastin fibers is believed to result in dilatation of 
the proximal aorta and transfer of load to stiffer elements of the aortic wall, such as collagen. 
As a consequence, aortic wall stiffness and pulse wave velocity are increased, resulting 
in the premature arrival of reflected pressure waves in late systole rather than diastole, 
(11) which increases central pulse pressure and as a consequence systolic blood pressure. (12) 
Higher systolic blood pressures increase left ventricular afterload, increasing myocardial work 
and resulting in concentric left ventricular hypertrophy, increased oxygen demand and 
subendocardial ischaemia.(13,14) This then links aortic stiffness to increased mortality 
via concentric left ventricular hypertrophy. 
Indeed, obesity is linked to a predominantly eccentric pattern of hypertrophy rather than 
the concentric pattern of hypertrophy which would be expected with increased proximal 
aortic stiffness. Furthermore, eccentric hypertrophy is less predictive of cardiovascular events 
than concentric remodeling. (15,16) 
  
Hence, although attractive as potential mediators of cardiovascular risk, it is feasible that 
obesity related changes in aortic stiffness, being predominantly in the abdominal aorta, are not 
acting to increase pulse pressure and produce concentric left ventricular hypertrophy, but 
rather that obesity is linked, via increased blood volume, to an eccentric pattern of 
hypertrophy and independently produces distal aortic stiffness via obesity dependent 
processes which have no bearing on left ventricular mass. 
We aimed to establish whether or not, in addition to the well-documented changes of eccentric 
hypertrophy and distal aortic stiffness in obesity, there was an element of concentric left 
ventricular remodeling that was predicted by increased ascending aortic stiffness. 
In order to do this we used cardiovascular magnetic resonance imaging to examine the 
relationship between regional aortic distensibility and left ventricular morphology in a cohort of 
normotensive subjects across a wide range of body mass index measures and compared this to 
a cohort of hypertensive subjects where the interplay between aortic stiffness and concentric 
left ventricular hypertrophy is more established. 
Methods 
Ethics and Study Cohort 
The study was approved by the local ethics committee, and informed written consent 
was obtained from each patient. In total, 301 subjects met criteria for inclusion into the 
study and were split in to two cohorts, normotensive and hypertensive, each with three 
subgroups according to body mass index. 
Normotensive Subjects 172 healthy subjects (60% female, BMI range 18.5-44.8kg/m2) were 
included into the normotensive subset of the study. All normotensive subjects were 
screened for the presence of identifiable cardiac risk factors and excluded if they had 
  
a history of cardiovascular disease, definite hypertension, diabetes, current smoking (or a 
greater than 2 pack year history of smoking), or use of cardiac medications. All subjects 
were normotensive at the time of scanning (taken as an average of three supine 
measures over ten minutes under 140/90mmHg, (Model; MandauTM digital 
sphygmomanometer, P.M.S Instruments Ltd, United Kingdom). Subjects were excluded if 
they had either a diabetic range fasting glucose level (≥ 6·7 mmol) or a fasting total 
cholesterol level ≥ 6·5 mmol, a history of coronary artery disease (CAD), or of cardiac 
chest pain or valvular heart disease. For analysis subjects were separated into three groups 
according to WHO body mass index category (normal weight normotensive, n = 79), 
overweight normotensive, (n = 42) and obese normotensive (n = 51)). 
Hypertensive Subjects 129 subjects (female 60%, BMI range 19.9 – 48.5) were recruited to 
this study. Subjects were deemed hypertensive if a history of hypertension was 
present or hypertension was confirmed on 24hr blood pressure monitoring (Model, 
TM2420 PMS Instruments Ltd, Maidenhead, UK) or clinic blood pressure monitoring as 
above MandauTM digital sphygmomanometer [P.M.S (Instruments) Ltd, United Kingdom]. 
Subjects were excluded if they had a history of diabetes, hypercholesterolaemia, 
established cardiovascular disease, coronary disease or had a history of smoking, current 
smokers were also excluded. As with the normotensive cohorts subjects were separated into 
three groups according to body mass index (normal weight hypertensive BMI 18.5 (n = 31), 
overweight hypertensive (n = 51) and obese hypertensive (n=47)). 
Aortic Imaging 
All MR scans for the assessment of left ventricular morphology and aortic distensibility were 
performed on a 1.5 Tesla MR system (Siemens Healthcare, Erlangen, Germany) (17). Indices 
  
of aortic function were assessed using an SSFP cine sequence with the following parameters: 
TR 42 ms, TE 1.4 ms, FOV read 380 mm, in plane resolution 1.97 mm, slice thickness 7 mm. 
Based on sagittal-oblique pilot images aligned with the aortic arch, aortic cine images were 
acquired in transverse planes at 3 levels: the crossing of the pulmonary arch through 1) 
the ascending thoracic aorta (Ao), 2) descending thoracic aorta (PDA) and 3)12 cm below 
this slice in the abdomen (DDA) as previously described (18). The abdominal cine 
images were piloted perpendicular to the orientation of the abdominal aorta. During the 
acquisition of the images, a brachial blood pressure was recorded (DINAMAP 1 846-SX, 
Critikon Corp) to provide the systolic (Ps) and diastolic (Pd) aortic pressures at the same 
time as the volume images were being acquired. 
Left Ventricular Imaging 
All imaging was prospectively cardiac gated with a precordial four lead ECG and 
acquired during end expiration breathold. Images were acquired using a steady state free 
precession (SSFP) sequence with an echo time (TE) of 1·5ms, a repetition time (TR) of 
3·0ms, temporal resolution 47·84ms and a flip angle of 60◦ as previously described. (14-16) 
SSFP cine sequences were used to acquire localisation images followed by a SSFP left and 
right ventricular short axis stack of contiguous images with a slice thickness of 7mm and an 
interslice gap of 3mm. 
 
Data Analysis 
Left Ventricle  
Image analysis for left ventricular volumes and mass was performed using Siemens 
analytical software (ARGUS©). The short axis stack was analysed manually contouring the 
endocardial borders from base to apex at end-diastole and end-systole. The epicardial 
  
border was contoured at end-diastole to yield myocardial mass. Left ventricular mass (g) 
was calculated as the epicardial volume minus the endocardial volume multiplied by 
1·05 (specific gravity of myocardium). The inter-observer and intra-observer coefficient 
of variation for left ventricular mass measures with this method is excellent, and has been 
previously reported. (19) 
Aortic Imaging  
Aortic cross sectional area in systole (Amax) and diastole (Amin) was calculated using an 
automated in house software program within Matlab 6.5©, and vascular distensibility was 
calculated as previously described. (20) Aortic distensibility (AD) represents the relative 
change in area of the aorta per unit pressure, taken here as the pulse pressure and is 
calculated according to the formula: Aortic Distensibility = (Amax -Amin)/Amin/(Pmax − 
Pmin), where Amax = maximal (systolic) area (mm2), Amin = minimal (diastolic) area (mm2), 
Pmax = systolic blood pressure (mm Hg), and Pmin = diastolic blood pressure (mmHg). The 
coefficient of variation of this automated method is 0.32% for intra-study repeat analysis 
and 2.18% for inter-study repeated acquisition and analysis.(21) 
 
Statistical Analysis 
All statistics were analysed using a commercial software package (SPSS 15; SPSS, Chicago, 
Ill). All results are presented as the mean ± standard deviation. All data were 
subjected to Kolmogorov-Smirnov tests to establish normal distribution of the data. Data 
groups were compared using a one way ANOVA technique with post hoc Bonferroni 
correction. Any differences were considered significant at p < 0·05. The associations 
between left ventricular mass: volume ratio and aortic distensibility were analysed initially 
  
without any adjustments (crude model) and then with adjustments for potential confounders 
(adjusted models). Because left ventricular structure is known to be affected by gender, body 
mass index and blood pressure these variables were considered in the adjusted models. 
Results 
Anthropometric data for the study groups is shown in Table 1. 
Blood Pressure 
There was no significant difference between systolic or diastolic blood pressures between the 
normotensive subgroups (p > 0.99, Table 1). Pulse pressure was also similar between the 
normotensive groups (p>0.99). As expected, both systolic and diastolic blood pressure 
measurements were larger in the hypertensive groups than in the normotensive groups (p<0.0 
1), but did not differ between the body mass index-separated subgroups. Pulse pressure 
followed a similar pattern, being greater in the hypertensive groups than in the 
normotensive groups but similar between hypertensive body mass index-separated 
subgroups (intergroup analyses; p < 0.01 and p>0.99 respectively). As expected, all 
hypertensive subgroups had higher systolic, diastolic and pulse pressure readings than their 
normal weight normotensive counterparts (Table 1). 
 
Body Mass Index 
As expected, both obese groups had larger body mass index values than overweight and 
normal weight groups (p<0.001). All overweight groups had larger body mass indices 
than normal weight groups (p<0.001). Normal weight, overweight and obese 
normotensives were well matched in body mass index to normal weight, overweight and 
obese hypertensives (Table 1). 
  
Aortic Size 
Diastolic Aortic Measurements  
Overweight normotensive and obese normotensive subjects had larger diastolic aortic cross- 
sectional areas than normal weight normotensive subjects at all three levels of the aorta. 
(p<0.001 for all analyses). Overweight and obese normotensive subjects did not differ in 
diastolic aortic measurements at any level (p>0.99). Normal weight, overweight and obese 
hypertensive subjects all had larger diastolic aortic measurements than normal weight 
normotensive subjects (p<0.001, for all analyses) but diastolic aortic measurements 
between these hypertensive subgroups were similar (p>0.99 for all subgroup analysis, 
Table 1). Overweight and obese hypertensive patients were seen to have larger diastolic aortic 
areas than normotensive overweight and obese subjects (p<0.001, Table 1). 
Regional Distensibility Measures 
Although there was clearly a stepwise decrease in aortic distensibility with increasing body 
mass index at all three levels of the aorta measured, when analysed in body mass index-
separated subgroups, the reduction in aortic distensibility between normal weight 
normotensive subjects and overweight normotensive subjects did not reach statistical 
significance (p >0.10 for all analyses). Obese normotensive subjects had lower aortic 
distensibility than normal weight normotensive subjects at all levels recorded, with the 
absolute reduction being largest in the abdominal aortic area (ascending aorta by 22%, 
proximal descending aorta by 20%, abdominal aorta by 27%, p<0.01). Compared to normal 
weight normotensive subjects, normal weight, overweight and obese hypertensive subjects 
had substantially reduced aortic distensibility at all three levels (Table 1). In contrast to the 
normotensive groups, the largest reductions in distensibility were in the ascending aorta 
  
(normal weight hypertensive by 65 %, overweight hypertensive by 65 %, obese 
hypertensive by 61 %, p< 0.001, Table 1 & Figure 1). All hypertensive subgroups had 
similar but reduced aortic distensibility measurements (p>0.99 for all subgroup analyses). 
Overweight and obese hypertensives had lower aortic distensibility measures than their 
overweight and obese normotensive counterparts at all three levels measured (p<0.001). The 
effects of obesity and hypertension were seen to be additive in reducing aortic distensibility 
with aortic distensibility being not only significantly lower in obese normotensives than that 
recorded in normal weight normotensives but also significantly lower in obese 
hypertensives than obese normotensives. This pattern was seen across all three levels of the aorta 
(p<0.001 for all analyses, Table 1). 
Left Ventricular Characteristics 
Absolute Left Ventricular Mass  
Left ventricular mass was larger in both overweight and obese normotensive subjects 
than normal weight normotensive counterparts (by 21 % and 27 % respectively, p<0.001). 
Left ventricular mass was also larger in overweight and obese hypertensives than normal 
weight normotensives (by 27 % and by 33 % respectively, p<0.001). Overweight 
and obese hypertensives had similar left ventricular mass measurements to their normotensive 
counterparts (p>0.99 and p= 0.83 respectively). 
Left Ventricular Mass: Volume Ratio  
Amongst normotensive subjects, left ventricular mass: volume ratio was greater in both 
overweight and obese than in those with normal weight (p=0.02 & p=0.003 respectively). All 
hypertensive subgroups had larger left ventricular mass: volume ratios than normal weight 
normotensives (p< 0.001). Importantly, obese hypertensives had larger left ventricular 
  
mass: volume ratios than obese normotensives (by 15%, p=0.02 Table 1 & Figure 1), 
suggesting that obesity is acting in an incremental way to increase concentric remodeling. 
Aortic Distensibility and Left Ventricular Mass: Volume Ratio: Crude Associations  
To assess the effects of hypertension on regional aortic distensibility, and reduce the impact 
of body mass index, all normal weight subjects including all hypertensive subjects were 
pooled into a ‘hypertension subset’ for analysis (n=120, female 60%, blood pressure 
range SBP 90- 183mmHg, DBP 55-105mmHg). Pearson correlation revealed that ascending 
aortic distensibility, proximal aortic distensibility and abdominal aortic distensibility were 
negatively correlated with left ventricular mass volume ratio (Table 2). 
To assess the effects of body mass index on left ventricular mass: volume ratio, and reduce 
the effects of blood pressure, all normotensive subjects were pooled into a ‘normotensive 
subset’ for this analysis including all levels of body mass index (n=172, 60% female, BMI 
range 18.5- 44.8kg/m2). Pearson correlation revealed that ascending aortic distensibility 
and proximal descending aortic distensibility were negatively correlated to left ventricular 
mass: volume ratio (Table 2). There was no correlation between abdominal aortic 
distensibility and left ventricular mass volume ratio (p=0.10). 
To assess the combined effects of obesity and hypertension all hypertensive patients across 
all body mass index values were pooled into a ‘combined subset’ for this analysis (n=129, 
female 58%, BMI range 19.9-48.5 kg/m2, BP range SBP 115-211 mmHg, DPB 63 -1 13mmHg). 
Pearson correlation revealed that in this subset there were no significant correlations between 
ascending aortic distensibility, proximal aortic distensibility or abdominal aortic 
distensibility and left ventricular mass volume: ratio (Table 2). 
  
Aortic Distensibility and Left Ventricular Mass: Volume Ratio: Adjusted Associations  
In the hypertensive subset, despite only including normal weight subjects, there was a 
significant positive association between body mass index and left ventricular mass: volume 
ratio (Table 2). When adjusted for gender, body mass index and mean arterial pressure the 
negative correlation between ascending aortic distensibility and left ventricular mass: 
volume ratio remained significant (R= -0.33, p=0.01). As prescription of beta-blockers and/ 
or ace-inhibitors (ACEi) potentially has effects on vascular elasticity, we performed analysis 
adjusting for this in addition to above. This again showed that, when adjusting for gender, 
body mass index, mean arterial pressure and beta-blocker/ACEi usage, the negative correlation 
between ascending aortic distensibility and left ventricular mass: volume ratio remained 
significant (R= -0.24, p=0.02). This suggests that in the hypertensive subset increased 
ascending aortic stiffness is acting to produce increased concentric hypertrophy independent 
of body mass index and blood pressure. 
Despite only including normotensive subjects into the normotensive subset there was a 
significant positive correlation between all blood pressure measurements (systolic blood 
pressure, diastolic blood pressure, mean arterial pressure and pulse pressure) and left 
ventricular mass: volume ratio (Table 2). After adjusting for mean arterial pressure there 
was no significant association between ascending aortic distensibility and left ventricular mass: 
volume ratio in the normotensive subset (R= -0.14, p=0.14). The positive correlation 
between body mass index and left ventricular mass: volume ratio remained after adjusting 
for gender, mean arterial pressure and ascending aortic distensibility (R= 0.35, p=0.01). 
This suggests that obesity is indeed acting to produce an additional concentric element of 
hypertrophy, and that this process is independent of the effect of mean arterial blood 
pressure. Unlike the hypertensive subgroup, however, this pattern is not related to ascending 
  
aortic stiffness. 
Discussion  
Given the global increase in obesity and its association with mortality, further 
understanding of the ways in which obesity acts to increase mortality is of great clinical 
importance. Candidate mechanisms to explain this are aortic stiffness and increased left 
ventricular mass, both of which are present in obesity and have been shown to be predictors 
of cardiovascular events in many patient groups. However, obesity is linked to a 
predominantly distal pattern of increased aortic stiffness primarily affecting the abdominal 
aorta, quite different to that seen in hypertension and other patient cohorts, and to 
predominantly eccentric hypertrophy rather than the concentric pattern which reportedly 
stronger links to mortality. (22) To date, no study has investigated whether ascending aortic 
stiffness is linked to a concentric remodeling process in obesity in a pattern similar to that 
reported in hypertension. We have analysed the relationship between regional aortic 
stiffness (as assessed by aortic distensibility) and left ventricular remodeling (as assessed 
by left ventricular mass: volume ratio) in a group of normotensive obese subjects and 
compared this to a group of normal weight hypertensive subjects. 
 
We have shown, in contrast to hypertension, where increased ascending aortic stiffness is 
related to concentric remodeling independent of the effects of systolic blood pressure and 
body mass index, that despite the fact that additional concentric remodeling does occurs 
in obesity, independent of systolic blood pressure, this is not related to increased ascending 
aortic stiffness when the effects of systolic blood pressure were removed. 
The most widely accepted mechanism by which aortic stiffness increases mortality involves 
  
degradation of elastin fibers in the proximal aorta resulting in dilatation and resultant transfer 
of load to stiffer collagenous elements. The increased stiffness accelerates reflected pressure 
waves which consequently arrive in late systole rather than diastole, (11) increasing central 
pulse pressure and systolic blood pressure (12) resulting in concentric left ventricular 
hypertrophy, increased oxygen demand and subendocardial ischaemia. (13,14) In 
keeping with this, as expected, the hypertension subset had the greatest aortic dilatation 
and reduction in distensibility measures in the ascending aorta and, in addition to this, 
ascending aortic stiffness was seen to be negatively correlated with left ventricular mass: 
volume ratio, in agreement with the proposed mechanism outlined above. 
In comparison to the hypertension subset where concentric remodeling predominated, the 
effect of increasing obesity in the normotensive subset was a more eccentric pattern of 
hypertrophy (as evidenced by significantly lower left ventricular mass: volume ratio). 
However, the left ventricular mass: volume ratios were still significantly elevated in the 
overweight and obese normotensive cohorts when compared to their normal weight 
normotensive counterparts confirming that, despite a predominantly eccentric pattern of 
hypertrophy, an element of concentric hypertrophy is also present. Elevated blood 
pressure appears not to be the cause of this concentric hypertrophy as values were well 
within the normal range, similar for all normotensive groups. In addition, body mass 
index remained positively correlated with left ventricular mass: volume ratio when adjusted 
for mean arterial pressure. 
As with the hypertensive cohort, but to a lesser extent, the ascending aorta in the obese 
normotensive group was seen to be significantly dilated when compared to normal weight 
normotensive subjects, and was significantly stiffer, again to a lesser degree than in 
hypertension. Furthermore, ascending aortic distensibility was correlated negatively with left 
  
ventricular mass: volume ratio on crude analysis. Although initially this would indicate that 
ascending aortic stiffness in obesity is related to increased left ventricular mass: volume 
ratios and thus to an additional element of concentric remodeling, when the effects of 
blood pressure were removed this relationship became non significant. 
This suggests that obesity is acting to produce left ventricular hypertrophy via two distinct 
haemodynamic effects. Firstly, the excess fat mass associated with obesity is known to 
increase metabolic demand and, thus, both cardiac output and total blood volume are 
elevated. These circulatory changes are known to cause left ventricular geometric 
remodeling in the form of cavity dilatation (confirmed again in this study), which leads to a 
compensatory eccentric left ventricular hypertrophy in response to increased wall stress. 
(23,24) Secondly, this study has shown, in obesity, that in addition to the eccentric 
hypertrophy there is an element of concentric remodeling that is related to body mass 
index, independent of systolic blood pressure and not related to proximal aortic stiffness. An 
explanation for this may be that the inter-relationships between obesity and left ventricular 
mass are more complex than simple haemodynamic effects, and involve adipokine-
mediated mechanisms. Increased visceral and subcutaneous adiposity is known to cause 
higher levels of serum leptin, a hallmark of human obesity, and 
hyperinsulinaemia, both of which have been linked to ventricular hypertrophy in humans and 
in animal models, and as such it is likely that there are multiple processes occurring in 
parallel to cause left ventricular mass increases in obesity. In addition, when obesity and 
hypertension coexist, we have shown that left ventricular mass volume ratio is greater than 
that recorded in hypertension alone suggesting an additive effect of the two pathologies in 
producing left ventricular hypertrophy. 
Interestingly, this study has highlighted that the pattern of distensibility changes in obesity 
  
differ from those in hypertension, with a predominantly distal pattern of stiffness seen in obesity 
and a predominantly proximal pattern seen in hypertension. The reasons for this are not 
known but aortic distensibility changes in the setting of obesity have been attributed to a 
number of factors that are not present in hypertension including; hyperleptinaemia 
(25), external physical compression from adipose tissue, (26) elevated circulatory 
inflammatory cytokines (27) and increased free fatty acid levels (28). In addition to this, 
obese individuals have an excess of abdominal visceral fat, which not only is a better 
predictor of cardiovascular and metabolic risk than total body fat alone but is also linked to 
altered vascular function. (29) Therefore, it is likely that obesity- related processes known to 
affect vascular function are affecting all sections of the aorta, but their effect is greatest on 
the areas which are least elastic, i.e. the abdominal sections. 
Limitations  
The duration of hypertension and obesity has not been recorded in this study and will 
have an impact on left ventricular and aortic measures. In addition a proportion of the 
hypertensive subjects were on blood pressure lowering medication (normal weight 36%, 
overweight 37%, obese 34%) which may again have had influences on left ventricular 
measures. However, the percentage of subjects taking blood pressure lowering medication 
was not different between hypertensive subgroups and therefore is unlikely to have biased 
one particular group. 
Conclusion  
This study has shown, in agreement with published data, that proximal aortic dilatation and 
increased proximal aortic stiffness is linked to concentric left ventricular hypertrophy in 
  
hypertension, in line with the concept of aortic-ventricular coupling. We have also shown 
that despite the predominantly eccentric pattern of hypertrophy in obesity, there is a 
concentric element of hypertrophy that occurs independent of systolic blood pressure but is 
not linked to increased ascending aortic stiffness. As ascending aortic stiffness is thought to 
be one of the mechanisms by which cardiovascular risk is increased, via increased left 
ventricular concentric remodeling, it is unlikely that obesity is acting via similar 
mechanisms given the lack of relationship between ascending aortic stiffness and left 
ventricular mass: volume ratios reported in this study in obesity. 
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Figure 
 
 
Figure 1. Left Ventricular: Mass Volume Ratio and Ascending Aortic Distensibility across the 
Study Groups
  
Table 1. Study groups anthropometric, left ventricular and aortic parameters (statistical significances described in text) 
 Normal Weight 
Normotensive 
N =79 
Overweight 
Normotensive 
N =42 
Obese 
Normotensive 
N=51 
Normal Weight  
Hypertensive 
N=31 
Overweight 
Hypertensive 
N=51 
Obese 
Hypertensive 
N =47 
Body Mass Index (kg/m2) 22 ± 2 27 ± 1 35 ± 4 23 ± 1 28 ± 1 34 ± 4 
Systolic Blood Pressure(mmHg) 117±11 123±12 120±13 142±15 149±15 151±18 
Diastolic Blood Pressure(mmHg) 73±8 77±9 76±9 83±9 85±9 87±11 
Pulse Pressure (mmHg) 44 ± 8 45 ± 9 45 ± 10 61 ± 16 65 ± 15 64 ± 16 
Diastolic Ascending Aortic Area (mm2) 489 ± 146 620 ± 148 598 ± 162 698 ± 148 732 ± 193 746 ± 219 
Systolic Ascending Aortic Area (mm2) 595± 152 725± 155 700± 168 753± 138 805± 192 821±226 
Diastolic Proximal Descending Aortic Area 
(mm2) 
295 ± 78 342 ± 90 336 ± 98 379 ± 77 396 ± 94 388 ± 104 
Systolic Proximal Descending Aortic Area 
(mm2) 
356 ± 80 399 ± 90 396 ± 102 420 ± 79 446 ± 100 443 ± 120 
Diastolic Abdominal Aortic Area (mm2) 220 ± 60 268 ± 75 259 ± 60 340 ± 99 324 ± 67 319 ± 73 
Systolic Abdominal Aortic Area (mm2) 287 ± 65 330 ± 79 324 ± 67 394 ± 98 386 ± 83 372 ± 71 
Ascending Aortic Distensibility (mmHg-1) 5.5 ± 3.1 4.2 ± 2.5 4.1 ± 2.1 1.8 ± 1.3 2.0 ± 1.9 2.2 ± 1.3 
Proximal Descending Aortic Distensibility 
(mmHg-1) 
5.1 ± 2.1 4.5 ± 2.1 4.1 ± 1.7 2.3 ± 1.3 2.3 ± 1.2 2.4 ± 1.3 
Abdominal Aortic Distensibility (mmHg-1) 7.6 ± 3.1 6.3 ± 3.4 5.7 ± 2.4 3.2 ± 1.9 3.3 ± 1.8 3.3 ± 1.9 
Left Ventricular Ejection Fraction (%) 68 ± 6 68 ± 6 70 ± 7 72 ± 7 71 ± 9 72 ± 6 
Left Ventricular Mass(g) 101±26 120±28 125±32 114±23 132±36 138±41 
Left Ventricular End Diastolic Volume (ml) 134 ± 31 137 ± 26 145 ± 23 124 ± 26 140 ± 45 138 ± 27 
Left Ventricular Mass/Volume Ratio 0.77 ± 0.12 0.88 ± 0.15 0.87 ± 0.19 0.93 ± 0.17 0.96 ± 0.17 1.00 ± 0.19 
  
Table 2. Correlations of Left Ventricular Mass: Volume Ratio across Different Groups 
 
 
*= p<0.05 
 
  
LV Mass: Volume Ratio 
Normotensives  
(all BMI) 
Normal Weight  
(normotensive and 
hypertensive) 
Hypertensives      
(all BMI) 
(n= 172) (n=120) (n=129) 
Ascending Aortic Distensibility 
(mmHg-1) -0.19* -0.39* -0.01 
Proximal Descending Aortic 
Distensibility (mmHg-1) -0.14 -0.41* 0.01 
Abdominal Aortic Distensibility 
(mmHg-1) -0.10 -0.37* -0.01 
Pulse Pressure (mmHg) 0.20* 0.32* -0.11 
Systolic Blood Pressure (mmHg) 0.35* 0.31* -0.05 
Diastolic Blood Pressure (mmHg) 0.27* 0.01 0.11 
Mean Arterial Pressure (mmHg) 0.36* 0.23* 0.05 
Body Mass Index (kg/m2) 0.3* 0.27* 0.09 
